BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy flag Italy · Delayed Price · Currency is EUR
33.96
+0.01 (0.03%)
At close: May 2, 2025

BridgeBio Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
6,4595,0096,3541,0662,1597,125
Upgrade
Market Cap Growth
15.07%-21.16%496.14%-50.63%-69.70%84.61%
Upgrade
Enterprise Value
7,6296,4347,4442,1252,8706,984
Upgrade
PS Ratio
54.7923.37754.9214.6735.221056.59
Upgrade
PB Ratio
-4.26-3.56-5.23-0.91-2.8480.79
Upgrade
P/TBV Ratio
-----150.52
Upgrade
EV/Sales Ratio
67.9030.02884.5129.2546.811035.70
Upgrade
Debt / Equity Ratio
-1.13-1.19-1.30-1.38-1.994.60
Upgrade
Asset Turnover
0.150.300.020.100.080.01
Upgrade
Quick Ratio
4.314.443.044.036.346.35
Upgrade
Current Ratio
4.574.673.324.526.586.72
Upgrade
Return on Equity (ROE)
------173.15%
Upgrade
Return on Assets (ROA)
-48.27%-47.83%-64.08%-35.80%-41.75%-44.42%
Upgrade
Return on Capital (ROIC)
-91.66%-104.60%-85.54%-43.72%-48.94%-50.63%
Upgrade
Earnings Yield
-9.57%-10.33%-9.16%-42.24%-22.91%-5.15%
Upgrade
FCF Yield
-7.17%-10.06%-7.53%-37.25%-20.82%-4.67%
Upgrade
Buyback Yield / Dilution
-11.59%-14.30%-10.39%-2.16%-22.34%-12.27%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.